Clinical Trials Browser

OTHER × Adenocarcinoma × apatinib × Clear all

NCT06693128 2026-01-28

Camrelizumab Combined With or Without Apatinib and SOX of Neoadjuvant Treatment for Gastric Cancer

Phase 2 Active not recruiting

Adenocarcinoma

NCT04208347 2026-01-23

Perioperative Treatment of Combined SOX With Apatinib and Camrelizumab for Oesophagogastric Cancer

Phase 2/3 Active not recruiting

Adenocarcinoma

NCT03407976 2020-07-15

APPEASE

Phase 1 Terminated

Adenocarcinoma, Carcinoma, Transitional Cell